254 filings
Page 4 of 13
S-8
hyozais ka7zvhklrel
1 Mar 22
Registration of securities for employees
4:50pm
8-K
324 4ll88g
1 Mar 22
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
4:10pm
8-K
jtl bexvs6cpmw8f1b
10 Jan 22
Results of Operations and Financial Condition
7:00am
8-K
lessynad
21 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
30wbnb3o
20 Dec 21
Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection
7:00am
8-K
en7rrjmmcpci44raav
8 Nov 21
Cara Therapeutics Reports Third Quarter 2021 Financial Results
4:10pm
8-K
bl7t8mgyfayn
3 Nov 21
Cara Therapeutics Announces CEO Transition
8:10am
8-K
jj0f 91i9p3
31 Aug 21
Other Events
12:00am
8-K
zjlrxqpzidla50
23 Aug 21
Other Events
4:44pm
8-K
0b6g9 jhta
12 Aug 21
Regulation FD Disclosure
8:03am
8-K
2uzb55pex86ol
9 Aug 21
Cara Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm
8-K
lg480eyjqcae
4 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
6h27q ha4pbnh7ntl
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
jjtdee
10 May 21
Cara Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
8-K
n1kdkpq1oxnnc24f93h
29 Apr 21
Cara Therapeutics Announces Topline Results From
7:21am